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Abstract 
Objective To quantify the impact of the change in definition of severe pneumonia on 
documented pneumonia burden. 
Methods We reviewed existing data acquired during observational hospitalized 
pneumonia studies, before the introduction of the pneumococcal conjugate vaccine, 
in infants aged 2–23 months from Fiji, Gambia, Lao People's Democratic Republic, 
Malawi, Mongolia and Viet Nam. We used clinical data to calculate the percentage of 
all-cause pneumonia hospitalizations with severe pneumonia, and with primary end-
point consolidation, according to both the 2005 or 2013 World Health Organization 
(WHO) definitions. Where population data were available, we also calculated the 
incidence of severe pneumonia hospitalizations according to the different definitions. 
Findings At six of the seven sites, the percentages of all-cause pneumonia 
hospitalizations due to severe pneumonia were significantly less (P•<•0.001) according 
to the 2013 WHO definition compared with the 2005 definition. However, the 
percentage of severe pneumonia hospitalizations, according to the two definitions of 
severe pneumonia, with primary end-point consolidation varied little within each site. 
The annual incidences of severe pneumonia hospitalizations per 100•000 infants were 
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significantly less (all P•<•0.001) according to the 2013 definition compared with the 
2005 definition, ranging from a difference of −301.0 (95% confidence interval, CI: 
−405.2 to −196.8) in Fiji to −3242.6 (95% CI: −3695.2 to −2789.9) in the Gambia.  
Conclusion The revision of the WHO definition of severe pneumonia affects 
pneumonia epidemiology, and hence the interpretation of any pneumonia intervention 
impact evaluation. 
Introduction 
Pneumonia is the leading cause of post-neonatal deaths in children younger than 5 years, with 
much of deaths occurring in low- and middle-income countries.1,2 Several interventions exist 
that prevent pneumonia,3 including the pneumococcal conjugate vaccine; however, this 
vaccine is relatively expensive, meaning that governments require evidence of its health 
benefits in routine use. Such evidence is often provided by hospital admission data, but this 
requires a standardized pneumonia case definition as well as uniform admission criteria for 
pneumonia. To improve the case management of pneumonia in low- and middle-income 
countries, the World Health Organization (WHO) developed the Integrated Management of 
Childhood Illness guidelines in 1995. 
In 2005, these guidelines4 defined severe pneumonia as the presence of cough or 
difficulty in breathing and tachypnoea (>•50 breaths per minute for children aged 2–
11 months and >•40 breaths per minute for children aged 12–59 months) plus lower chest 
indrawing, and one or more of the general danger signs, which include: an inability to drink; 
persistent vomiting; convulsions; lethargy; unconsciousness; stridor in calm child; severe 
malnutrition (as documented in the medical records); central cyanosis; or a saturation of 
oxygen of <•90% in room air. Many low- and middle-income countries adopted these criteria. 
However, equivalence and non-inferiority studies found no difference in treatment failure 
rates between patients with pneumonia with lower chest indrawing who were treated with 
parenteral antibiotics in hospital, and outpatient treatment with oral antibiotics.5,6 As a result, 
WHO modified the classification of pneumonia severity;7 the 2013 definition of severe 
pneumonia requiring hospital admission is the presence of cough or difficulty in breathing 
and tachypnoea plus one or more of the general danger signs, but not lower chest indrawing.  
Between 2010 and 2013, before the WHO case definition for severe pneumonia was 
revised, more than 54 countries, supported by Gavi, the Vaccine Alliance, implemented the 
pneumococcal conjugate vaccine.8 The impact of this change in case definition on the 
documented burden of severe pneumonia is unclear. 
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We therefore assess clinical data describing pneumonia hospitalizations in six 
countries and determine the effect of the revised WHO 2013 definition of severe pneumonia 
on the proportion of all-cause hospitalized pneumonia cases that are classified as severe, and 
on the incidence of severe hospitalized pneumonia. We also explore the impact of this change 
in the case definition on radiological pneumonia, that is, patients with primary end-point 
consolidation evident from chest X-ray. Using observational data from seven sites, two from 
the African Region and five from the Western Pacific Region, we describe the epidemiology 
of severe pneumonia using both the 2005 and 2013 WHO definitions. We quantify the 
apparent reduction of hospitalized pneumonia cases with severe pneumonia, as well as the 
apparent fall in annual incidence of severe pneumonia hospitalizations with primary end-
point consolidation, resulting directly from the change in definition of severe pneumonia. 
Methods 
Data sources 
We requested data from investigators undertaking retrospective or prospective hospitalized 
pneumonia studies in children aged 2–23 months from seven sites in six countries before the 
introduction of the pneumococcal conjugate vaccine: Fiji, Gambia,9 Lao People's Democratic 
Republic, Malawi,10–12 Mongolia and Viet Nam (with separate data sets for Hanoi and Ho Chi 
Minh City; Table 1). We reviewed the individual medical records of patients from all sites 
and extracted clinical information, including: age, respiratory rate and the presence of lower 
chest wall indrawing, stridor when calm or any general danger signs (inability to drink or 
vomiting everything, convulsions, lethargy or unconsciousness). Further details on the data 
collection methods at each study site are available from the corresponding author. 
Data processing 
We used the extracted clinical information to classify pneumonia cases as severe according to 
the 2005 and 2013 WHO definitions of severe pneumonia and calculated the median age (in 
months) and interquartile range of patients for each site. We compared the different median 
ages of the children with severe pneumonia according to the different definitions using the 
non-parametric K-sample test on the equality of medians. We also calculated the percentage 
of all-cause pneumonia hospitalizations with lower chest wall indrawing. 
For those sites at which radiography data were collected (Fiji, Gambia, Mongolia and 
Viet Nam), an experienced radiologist, blind to the clinical findings, reinterpreted all chest 
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radiographs to determine the presence of primary end-point pneumonia according to WHO 
criteria.14,15 
Where population data and a defined catchment population were available (Fiji, 
Gambia, Mongolia and Ho Chi Minh City in Viet Nam), annual incidence rates with 95% 
confidence intervals (CI) of hospitalizations from severe pneumonia according to both 
definitions, as well as the incidence of patients with primary end-point consolidation, were 
calculated per 100•000 infants aged 2–23 months. The differences in these incidence rates, 
with 95% CIs, were calculated using standard errors where appropriate.  
We conducted all statistical analyses using the software Stata, version 14.0 
(StataCorp. LLC, College Station, United States of America). 
Results 
Our analysis of the impact of the change in definition of severe pneumonia included 24•287 
pneumonia hospitalizations of children aged 2–23 months (Table 1). The median ages of 
hospitalized pneumonia patients with severe pneumonia according to either the 2005 or 2013 
definition ranged from 5 months in Hanoi to 12 months in Mongolia, and did not differ 
significantly by pneumonia case definition at each site (all P•>•0.05; Table 2). 
The percentage of all-cause pneumonia hospitalizations with lower chest wall 
indrawing ranged from 64.5% (169/262) in Hanoi to 97.4% (15•300/15•709) in Malawi 
(Table 3). At six of the seven sites, the percentages of all-cause pneumonia hospitalizations 
due to severe pneumonia were significantly less (all P•<•0.001) according to the 2013 WHO 
definition compared with the 2005 definition (Table 3). The percentage differences ranged 
from −7.0% (95% CI: −17.0 to 2.6) in Ho Chi Minh City to −49.9% (95% CI: −51.4 to 
−48.4%) in Malawi. When classifying severe pneumonia by the 2013 definition compared 
with the 2005 definition, the largest reductions were observed in data from the Gambia 
(−47.0; (733−285)/953) and Malawi (−49.9; (11•163−3327)/15•709). Between sites, the 
percentage of all-cause pneumonia hospitalizations due to severe pneumonia, according to the 
2005 definition, varied from 50.0% (190/380) in Ho Chi Minh City to 81.9% (555/678) in 
Lao People's Democratic Republic; when adopting the 2013 definition, this ranged from 
21.2% (3327/15•709) in Malawi to 56.6% (384/678) in Lao People's Democratic Republic. 
The percentage of severe pneumonia hospitalizations with primary end-point consolidation 
varied little within each site between the two definitions of severe pneumonia, from a 
reduction of 5.0% (1/71 to 10/155) at Hanoi to an increase of 1.2% in both the Gambia 
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(60/285 to 146/733) and in Ho Chi Minh City (20/163 to 21/190). Between sites, however, 
the percentage of severe pneumonia hospitalizations with primary end-point consolidation 
varied from 6.5% (10/155) in Hanoi to 19.9% (146/733) in the Gambia according to the 2005 
WHO definition, and varied from 1.4% (1/71) in Hanoi to 21.1% (60/285) in the Gambia 
using the 2013 definition. 
Table 4 summarizes the annual incidences of all-cause pneumonia hospitalizations 
due to severe pneumonia according to both 2005 and 2013 definitions of severe pneumonia, 
as well as the differences in these incidences. At all sites for which relevant data were 
available, the annual incidences were significantly less (all P•<•0.001) according to the 2013 
definition compared with the 2005 definition, ranging from a difference of −301.0 (95% CI: 
−405.2 to −196.8) in Fiji to −3242.6 (95% CI: −3695.2 to −2789.9) in the Gambia. Between 
sites, the annual incidence of pneumonia hospitalizations with primary end-point 
consolidation ranged from 160.7 (95% CI: 137.7 to 186.5) in Fiji to 1056.8 (95% CI: 892.3 to 
1242.7) in the Gambia when severe pneumonia was classified according to the 2005 
definition, and ranged from 138.4 (95% CI: 117.1 to 162.5) in Fiji to 529.9 (95% CI: 324.0 to 
817.3) in Ho Chi Minh City when using the 2013 definition. The annual incidences of 
pneumonia hospitalizations with the presence of primary end-point consolidation were 
significantly different according to the definition of severe pneumonia used in data from 
Gambia, Mongolia and Ho Chi Minh City in Viet Nam (P•<•0.001), but the difference was 
not significant in the data from Fiji (P•=•0.09). 
Discussion 
We have shown that, in six out of seven sites from the African and Western Pacific Regions, 
the percentage of pneumonia hospitalizations in children aged 2–23 months with severe 
pneumonia was significantly less using the 2013 definition of severe pneumonia compared 
with the 2005 definition. Similarly, at sites where incidence could be calculated, we have 
demonstrated that the annual incidence of pneumonia hospitalizations with severe pneumonia 
was significantly less using the 2013 definition of severe pneumonia compared with the 2005 
definition. These findings are not unexpected given that the presence of lower chest wall 
indrawing (without danger signs) is no longer included in the 2013 WHO case definition for 
severe pneumonia;8 we calculated that 64.5 to 97.4% of hospitalized pneumonia cases had 
lower chest wall indrawing.  
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An unpublished review (Nordgren M, XXXXX, personal communication, 2016) of 
the impact of the pneumococcal conjugate vaccine on pneumonia burden in infants younger 
than 2 years from observational studies and double-blinded randomized controlled trials, 
using the case definitions all-cause pneumonia, WHO-defined pneumonia (year not specified) 
and pneumococcal pneumonia, found much variability. The varying sensitivity and 
specificity of the different case definitions9,16,17 mean that the magnitude of the impact of the 
vaccine on pneumonia calculated from studies of different design and using different case 
definitions cannot be directly compared. 
Primary end-point consolidation has moderate sensitivity and specificity, and is the 
end-point which has shown reasonable consistency within clinical trials.18,19 However, in 
low- and middle-income countries, whether an infant receives a chest radiograph is often 
determined by clinical severity; those with danger signs (and not lower chest wall indrawing) 
are more likely to receive a radiograph compared with those without, irrespective of which 
WHO severe pneumonia definition is used. Unfortunately, we were unable to compare the 
percentage of pneumonia hospitalizations with danger signs, as each site used slightly 
different definitions of danger signs; this may explain why our findings show that, within 
each site, the changes to the definition of severe pneumonia had no significant effect on the 
percentage of severe pneumonia hospitalizations with radiological pneumonia. However, the 
incidence of pneumonia hospitalizations with primary end-point consolidation was 
significantly different, depending on the definition of severe pneumonia, within three of the 
four sites for which data were available. 
Unsurprisingly, we observed variability in the incidence of pneumonia 
hospitalizations with severe pneumonia between sites, regardless of the case definition used. 
The incidence of hospitalized pneumonia is affected by many factors, including income, 
comorbidities and exposure to air pollution;20,21 variability between countries in hospitalized 
pneumonia burden is therefore to be expected. In addition, the incidence of pneumonia 
hospitalizations with severe pneumonia is also influenced by access to care and admission 
criteria.22 For example, despite being tertiary facilities, both Vietnamese sites had a lower 
percentage of pneumonia admissions that were severe according to the 2005 definition than 
compared with other sites, indicating a lower threshold for admission and/or better health-
seeking behaviour. A recent study has reported that many children with non-severe 
respiratory disease are admitted to primary, secondary and tertiary care facilities in Viet 
Nam.23 We found that the presence of lower chest wall indrawing varied between the two 
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Vietnamese sites, suggesting that the admission criteria also vary between these hospitals. 
Furthermore, the diagnosis of lower chest wall indrawing is observer dependent, also 
affecting within-site observations.24 Although the presence of danger signs was not recorded 
consistently between the sites, the key clinical criteria of severe pneumonia using either the 
2005 or 2013 severe pneumonia definition (age-specific respiratory rate, cough and presence 
of lower chest wall indrawing) were recorded consistently at each site, making within-site 
comparisons possible.  
The change from the 2005 to 2013 severe pneumonia case definition aimed to 
simplify the pneumonia treatment algorithm for community health workers and reduce 
unnecessary burden on families and health-care services.25 However, our findings need to be 
considered when discussing changes in the epidemiological impact on pneumonia burden and 
pneumonia impact evaluation. If clinicians have changed their admission criteria for 
pneumonia in accordance with changes in WHO guidelines, then the incidence of pneumonia 
hospitalizations will appear to decline regardless of any intervention, because of children 
with pneumonia and lower chest indrawing (no danger signs) now being managed as 
outpatients. For pneumonia epidemiology and pneumonia intervention evaluations, our 
findings highlight the importance of stating which WHO definition is used and whether 
admission criteria changed during the observation period. Further studies are also required to 
understand the impact of this definitional change in high-mortality settings, where rates of 
bacterial pneumonia are increased and lower chest wall indrawing has been identified as an 
independent risk factor for mortality.26 
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Table 1. Impact study of WHO severe pneumonia case definition change: data sources in 
six countries 
Country, city or 
region 
Hospital (level of care) Study design Period No. all-cause 
pneumonia 
hospitalizations 
of children aged 
2–23 months 
WHO 
guidelines 
used 
Fiji, Suva Colonial War Memorial 
Hospital (tertiary) 
Retrospective 2007 to 2011 3254 2005 
Gambia, Upper 
River Region 
Basse health centre 
(primary and 
secondary) 
Prospective9 May 2008 to 
Aug 2009 
953 None; study-
specific 
criteria13 
Lao People's 
Democratic 
Republic, 
Vientiane 
Mahosot, Settathirath, 
Hospital 103, National 
Child, Mother and Child 
Hospitals (tertiary); nine 
district hospitals 
(secondary) 
Retrospective 2011 to 2013 678 2005  
Malawi 16 out of 24 district 
hospitals (secondary) 
Prospective10–
12 
Oct 2000 to 
Jun 2003 
15•709 2005a 
Mongolia, 
Ulaanbaatar 
Four district hospitals 
(secondary), National 
Mother and Child 
Hospital (tertiary) 
Prospective April 2015 to 
May 2016 
3051b 2005  
Viet Nam, Hanoi National Children’s 
Hospital (tertiary) 
Retrospective 2010 262c None 
Viet Nam, Ho Chi 
Minh City 
Children’s Hospital 
No. 2 (tertiary) 
Retrospective 2010 380 2005 
WHO: World Health Organization. 
a Guidelines used were the same as the 2005 definition, although the study was performed before these guidelines 
were available. 
b Only children with clinical information included. 
c Every 10th pneumonia discharge in 2010 was included. 
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Table 2. Median age of pneumonia hospitalizations due to severe pneumonia in infants aged 
2–23 months in six countries 
WHO 
definition 
Median age in months (interquartile range)a  
Fiji Gambia Lao People's 
Democratic 
Republic 
Malawi Mongolia Viet Nam 
Hanoi Ho Chi 
Minh City  
20054 9 (5 to 14) 10 (6 to 17) 11 (6 to 16) 8 (5 to 13) 12 (7 to 17) 5 (3 to 11) 9 (5 to 15) 
20137 8 (5 to 13) 11 (6 to 18) 11 (6 to 15) 8 (5 to 13) 12 (7 to 17) 5 (3 to 9) 9 (5 to 16) 
P-value 0.346 0.789 0.275 0.924 0.640 0.156 0.126 
WHO: World Health Organization. 
a Median ages of children hospitalized with severe pneumonia compared using the non-parametric K-sample test on the 
equality of medians. 
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Table 3. Properties of all-cause pneumonia hospitalizations in infants aged 2–23 months in 
six countries 
Property of 
all-cause 
pneumonia 
Fiji (n•=•3254) Gambia 
(n•=•953) 
Lao 
People's 
Democratic 
Republic 
(n•=•678) 
Malawi 
(n•=•15709) 
Mongolia 
(n•=•3051) 
Viet Nam 
Hanoi 
(n•=•262) 
Ho Chi Minh 
City 
(n•=•380) 
With lower chest wall indrawing 
No. (%) 2665 (81.9) 711 (74.5) 443 (65.3) 15•300 (97.4) 2416 (79.2) 169 (64.5) 338 (88.9) 
With severe pneumonia 
No. (%) 
according to 
2005 WHO 
definition4 
2193 (67.4) 733 (76.9) 555 (81.9) 11•163 (71.1) 2337 (76.6) 155 (59.2) 190 (50.0) 
No. (%) 
according to 
2013 WHO 
definition7 
1838 (56.5) 285 (29.9) 384 (56.6) 3327 (21.2) 1422 (46.6) 71 (27.1) 163 (42.9) 
Percent 
difference 
(95% CI) 
−10.9 (−14.7 
to −7.1) 
−47.0 (−51.0 
to −43.1) 
−25.2 (−34.3 
to −16.4) 
−49.9 (−51.4 to 
−48.4) 
−30.0 (−33.9 
to −26.1) 
−32.1 (−43.3 
to −20.8) 
−7.1 (−17.0 
to 2.6) 
Of those with severe pneumonia, with primary end-point consolidationa 
No. (%) 
according to 
2005 WHO 
definition4 
238 (10.9) 146 (19.9) NA NA 268 (11.5) 10 (6.5) 21 (11.1) 
No. (%) 
according to 
2013 WHO 
definition7 
211 (11.5) 60 (21.1) NA NA 167 (11.7) 1 (1.4) 20 (12.3) 
Percent 
difference 
(95% CI) 
0.6 (−1.4 to 
2.7) 
1.2 (−2.7 to 
5.8) 
– – 0.3 (−2.0 to 
2.5) 
−5.0 (−9.9 to 
−0.1) 
1.2 (−5.9 to 
8.4) 
CI: confidence interval; NA: not available; WHO: World Health Organization. 
a Chest radiographs interpreted by independent radiologists, classifying primary end-point consolidation as per 
WHO definition.14 
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Table 4. Annual incidence of pneumonia hospitalizations with severe pneumonia in children 
aged 2–23 months in four countries 
Incidence Incidence per 100•000 infantsa (95% CI) 
Fiji Gambia Mongolia Viet Nam,  
Ho Chi Minh City 
All-cause pneumonia 
Annual incidence 
according to 2005 WHO 
definition4 
1671.4  
(1595.1 to 1750.5) 
530.4  
(4928.3 to 5703.8) 
4661.2  
(4649.7 to 672.3) 
5034.4  
(4358.7 to 5780.9) 
Annual incidence 
according to 2013 WHO 
definition7 
1370.4  
(1301.3 to 1442.2) 
2062.8  
(1830.3 to 2316.8) 
2836.2  
(2824.7 to 2847.3) 
4319.0  
(3692.8 to 5017.1) 
Difference −301.0  
(−405.2 to −196.8) 
−3242.6  
(−3695.2 to −2789.9) 
−1825.0  
(−2064.7 to −1585.3) 
−715.4  
(−718.5 to −712.3) 
With primary end-point consolidationb 
Annual incidence 
according to 2005 WHO 
definition4 
160.7  
(137.7 to 186.5) 
1056.8  
(892.3 to 1•242.7) 
534.5  
(515.1 to 552.9) 
556.4  
(344.8 to 849.3) 
Annual incidence 
according to 2013 WHO 
definition7 
138.4  
(117.1 to 162.5) 
434.3  
(331.4 to 559.0) 
333.1  
(314.1 to 351.9) 
529.9  
(324.0 to 817.3) 
Difference −22.3  
(−55.0 to 10.4) 
−622.5  
(−826.1 to −418.8) 
−201.4  
(−283.0 to −119.9) 
26.5  
(25.4 to 27.5) 
CI: confidence interval; NA: not available; WHO: World Health Organization. 
a Aged 2–23 months. 
b Chest radiographs interpreted by independent radiologists, classifying primary end-point consolidation as per WHO 
definition.14 
Note: The table only presents data for sites with available population data and a defined catchment.  
 
